13G Filing: Broadfin Capital and Aratana Therapeutics Inc. (PETX)

Page 10 of 10

Page 10 of 10 – SEC Filing

EXHIBIT A
Broadfin Capital, LLC is the relevant entity for which Kevin Kotler may be considered a control person.

Follow Aratana Therapeutics Inc. (NASDAQ:PETX)

Page 10 of 10